Teriflunomide (Aubagio) given green light in Pakistan MS fraternity welcomes the news that Aubagio (Teriflunomide) has been made available in Pakistan. The treatment is now available under the Named Patient Program, from October 2014. Aubagio 14 mg is a once-daily, oral therapy indicated in the European Union and also approved by FDA for the treatment of adult patients with relapsing-remitting multiple sclerosis. “This is an exciting development for the MS community in Pakistan who face daily challenges from their debilitating…